Examkin

Soru

Zorluk: ZorMeasures of Disease Frequency

A clinical epidemiologist is reviewing data from a large national registry for a chronic autoimmune condition. Two years ago, an international consensus committee introduced new diagnostic criteria for this condition. These new criteria incorporate advanced serologic testing, making them significantly more sensitive but slightly less specific than the historical criteria. Consequently, many patients with mild or early-stage symptoms are now formally diagnosed with the condition, whereas previously they were classified as having undifferentiated joint pain. The underlying biological incidence of the disease, the total population size, and the efficacy of available treatments have remained completely stable. Based on these changes, which of the following combinations best describes the expected impact on the reported epidemiological metrics for this condition?

  1. Reported incidence increases, prevalence increases, case fatality rate decreases, and disease-specific mortality rate remains unchanged.Cevap
  2. B
    Reported incidence increases, prevalence increases, case fatality rate remains unchanged, and disease-specific mortality rate decreases.
  3. C
    Reported incidence remains unchanged, prevalence increases, case fatality rate decreases, and disease-specific mortality rate remains unchanged.
  4. D
    Reported incidence increases, prevalence remains unchanged, case fatality rate increases, and disease-specific mortality rate increases.
  5. E
    Reported incidence increases, prevalence increases, case fatality rate decreases, and disease-specific mortality rate decreases.

Cevap

Reported incidence increases, prevalence increases, case fatality rate decreases, and disease-specific mortality rate remains unchanged.
The introduction of more sensitive diagnostic criteria artificially inflates the number of patients recognized as having the disease by capturing early and mild cases. This mathematically increases the numerators for both reported incidence (new cases) and prevalence (total cases). Because these mild cases are added to the total diagnosed pool without changing the absolute number of deaths (since treatment efficacy and true biological severity are unchanged), the case fatality rate (deaths per diagnosed cases) becomes diluted and decreases. However, the disease-specific mortality rate (deaths per total population) remains entirely unchanged because neither the absolute number of deaths nor the total population size was altered by the new diagnostic rules.

Adım Adım Çözüm

1
Determine the impact on reported incidence and prevalence.
Both increase.
Highly sensitive criteria identify early and mild cases that were previously missed. This adds more new cases to the numerator for incidence, and more total existing cases to the numerator for prevalence.
2
Analyze the components of Case Fatality Rate (CFR).
CFR decreases.
CFR is calculated as (Deaths from disease) / (Total diagnosed cases). The numerator (deaths) is constant because biology and treatments are unchanged, but the denominator (diagnosed cases) has significantly increased. A constant numerator over a larger denominator results in a lower CFR.
3
Analyze the components of Disease-Specific Mortality Rate.
Disease-specific mortality rate remains unchanged.
Mortality rate is calculated as (Deaths from disease) / (Total population). Both the number of deaths and the total population size are unchanged. Therefore, this metric remains completely stable.

Anahtar Kavram

Impact of changing diagnostic sensitivity on epidemiological metrics (Incidence, Prevalence, Case Fatality Rate, Mortality Rate).
Bu soruyu puanla

Konular

Measures of Disease Frequency

Bu konudan daha fazla soru